Pediatrics
-
Digital distraction is being integrated into pediatric pain care, but its efficacy is currently unknown. ⋯ Digital distraction provides modest pain and distress reduction for children undergoing painful procedures; its superiority over nondigital distractors is not established. Context, preferences, and availability should inform the choice of distractor.
-
Meta Analysis
Room Air for Initiating Term Newborn Resuscitation: A Systematic Review With Meta-analysis.
: media-1vid110.1542/5839981898001PEDS-VA_2018-1825Video Abstract CONTEXT: The International Liaison Committee on Resuscitation prioritized to rigorously review the initial fraction of inspired oxygen (Fio2) during resuscitation of newborns.
-
Review Meta Analysis
Lactobacillus reuteri to Treat Infant Colic: A Meta-analysis.
Lactobacillus reuteri DSM17938 has shown promise in managing colic, but conflicting study results have prevented a consensus on whether it is truly effective. ⋯ L reuteri DSM17938 is effective and can be recommended for breastfed infants with colic. Its role in formula-fed infants with colic needs further research.
-
Review Meta Analysis Comparative Study
Effectiveness of Tympanostomy Tubes for Otitis Media: A Meta-analysis.
Tympanostomy tube placement is the most common ambulatory surgery performed on children in the United States. ⋯ Tympanostomy tubes improve hearing at 1 to 3 months compared with watchful waiting, with no evidence of benefit by 12 to 24 months. Children with recurrent acute otitis media may have fewer episodes after tympanostomy tube placement, but the evidence base is severely limited. The benefits of tympanostomy tubes must be weighed against a variety of associated adverse events.
-
Review Meta Analysis
Prophylactic Early Erythropoietin for Neuroprotection in Preterm Infants: A Meta-analysis.
Recombinant human erythropoietin (rhEPO) is a promising pharmacological agent for neuroprotection in neonates. ⋯ Prophylactic rhEPO improved the cognitive development of very preterm infants, as assessed by the MDI at a corrected age of 18 to 24 months, without affecting other neurodevelopmental outcomes. Current and future RCTs should investigate optimal dosing and timing of prophylactic rhEPO and plan for long-term neurodevelopmental follow-up.